They further find that OPN plays a crucial role in promoting aggresiveness of lung cancer cells through its phosphorylation activation of the RON signaling pathway, implying its potential as a therapeutic target in the treatment of NSCLC. Here, SPP1 is linked to non-small cell lung carcinoma.